Insider Transactions in Q4 2023 at Atara Biotherapeutics, Inc. (ATRA)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 16
2023
|
Manher Joshi EVP, Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
12,287
-6.69%
|
$0
$0.39 P/Share
|
|
Nov 16
2023
|
Amar Murugan EVP, Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
8,307
-3.13%
|
$0
$0.39 P/Share
|
|
Nov 16
2023
|
Anh Co Nguyen President and CEO |
SELL
Open market or private sale
|
Direct |
8,856
-3.1%
|
$0
$0.39 P/Share
|
|
Nov 16
2023
|
Pascal Touchon President and CEO |
SELL
Open market or private sale
|
Direct |
20,409
-3.02%
|
$0
$0.39 P/Share
|
|
Nov 16
2023
|
Jill Henrich EVP, Global Head RA & Quality |
SELL
Open market or private sale
|
Direct |
3,267
-3.03%
|
$0
$0.39 P/Share
|
|
Nov 16
2023
|
Eric J Hyllengren EVP, CFO |
SELL
Open market or private sale
|
Direct |
11,958
-5.49%
|
$0
$0.39 P/Share
|
|
Nov 14
2023
|
Carol Giltner Gallagher |
BUY
Open market or private purchase
|
Direct |
90,980
+16.53%
|
$0
$0.31 P/Share
|
|
Nov 13
2023
|
Carol Giltner Gallagher |
BUY
Open market or private purchase
|
Direct |
179,020
+32.7%
|
$0
$0.22 P/Share
|
|
Nov 10
2023
|
Eric Dobmeier |
BUY
Open market or private purchase
|
Direct |
446,825
+44.23%
|
$0
$0.23 P/Share
|
|
Nov 10
2023
|
William K Heiden |
BUY
Open market or private purchase
|
Direct |
100,000
+32.36%
|
$0
$0.25 P/Share
|